Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Haematologica|February 25, 2021
Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemiaVincent Jachiet, Guillaume Moulis, Jérome Hadjadj, et al.Blood|September 19, 2025
VEXAS anemia is a mosaic erythroblastopeniaFrancois Rodrigues, Giulia Hardouin, Sara El Hoss, et al.RMD Open|July 22, 2022
Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patientsMohamed-Yacine Khitri, Alexis F Guedon, Sophie Georgin-Lavialle, et al.Rheumatology (Oxford, England)|April 18, 2026
Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndromeAlbrecht Betrains, Vincent Jachiet, Yannick Dieudonné, et al.Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter StudyTali Eviatar, Dafne Capelusnik, Corrado Campochiaro, et al.Clinical and Experimental Medicine|August 11, 2022
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseasesVincent Jachiet, Laure Ricard, Pierre Hirsch, et al.Journal of Neurology|February 1, 2025
Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.Annals of the Rheumatic Diseases|December 10, 2023
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registryBenjamin de Valence, Marion Delaune, Yann Nguyen, et al.American Journal of Hematology|July 8, 2025
Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell ClonesYoann Zadro, Amélie Lusque, Héloïse Rey, et al.Allergy|January 6, 2025
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter CohortGuillaume Lefèvre, Séverine Bleuse, Mathieu Puyade, et al.Pageof 4